Abstract
Parkin functions as an E3 ubiquitin ligase that monoubiquitylates and polyubiquitylates proteins to regulate a variety of cellular processes. It appears that parkin functions as a multipurpose neuroprotectant in a number of toxic paradigms, and loss of parkins E3 ligase activity seems to play a pathogenic role in both inherited and sporadic Parkinsons disease (PD). Increasing evidence indicates that posttranslational modifications play a major role in regulating parkins catalytic activity, solubility, substrate selection or subcellular localization. As some of these modification events are subject to pharmacological interventions, these findings may allow for new approaches in preventing or delaying PD onset and/or progression. Here, we review how posttranslational modifications can regulate this unique multifaceted ubiquitin ligase which plays a crucial role for the survival of dopaminergic neurons.
Keywords: Dopamine, parkin, phosphorylation, S-nitrosylation, ubiquitylation, neurodegeneration, Parkinsonapos;s disease, signaling, substrate, protein interaction, localization
Current Medicinal Chemistry
Title: Posttranslational Modifications as Versatile Regulators of Parkin Function
Volume: 18 Issue: 16
Author(s): E. Rubio de la Torre, P. Gomez-Suaga, M. Martínez-Salvador and S. Hilfiker
Affiliation:
Keywords: Dopamine, parkin, phosphorylation, S-nitrosylation, ubiquitylation, neurodegeneration, Parkinsonapos;s disease, signaling, substrate, protein interaction, localization
Abstract: Parkin functions as an E3 ubiquitin ligase that monoubiquitylates and polyubiquitylates proteins to regulate a variety of cellular processes. It appears that parkin functions as a multipurpose neuroprotectant in a number of toxic paradigms, and loss of parkins E3 ligase activity seems to play a pathogenic role in both inherited and sporadic Parkinsons disease (PD). Increasing evidence indicates that posttranslational modifications play a major role in regulating parkins catalytic activity, solubility, substrate selection or subcellular localization. As some of these modification events are subject to pharmacological interventions, these findings may allow for new approaches in preventing or delaying PD onset and/or progression. Here, we review how posttranslational modifications can regulate this unique multifaceted ubiquitin ligase which plays a crucial role for the survival of dopaminergic neurons.
Export Options
About this article
Cite this article as:
Rubio de la Torre E., Gomez-Suaga P., Martínez-Salvador M. and Hilfiker S., Posttranslational Modifications as Versatile Regulators of Parkin Function, Current Medicinal Chemistry 2011; 18 (16) . https://dx.doi.org/10.2174/092986711795843254
DOI https://dx.doi.org/10.2174/092986711795843254 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondria-Targeting Therapeutic Strategies for Overcoming Chemoresistance and Progression of Cancer
Current Medicinal Chemistry Immune Checkpoint Inhibitors: Basics and Challenges
Current Medicinal Chemistry Nanoparticles: A Neurotoxicological Perspective
CNS & Neurological Disorders - Drug Targets The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion
Current Cancer Drug Targets Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
Current Medicinal Chemistry Molecular and Cellular Activities of Vitamin E Analogues
Mini-Reviews in Medicinal Chemistry Red Blood Cell-Encapsulated L-Asparaginase: Potential Therapy of Patients with Asparagine Synthetase Deficient Acute Myeloid Leukemia
Protein & Peptide Letters Combating Protein Misfolding and Aggregation by Intracellular Antibodies
Current Molecular Medicine Omega-3 Polyunsaturated Fatty Acids and Cancer
Anti-Cancer Agents in Medicinal Chemistry Mechanisms Involved in BACE Upregulation Associated to Stress
Current Alzheimer Research Secondary Neoplasms in Children Treated for Cancer
Current Pediatric Reviews Collective Roles of Molecular Chaperones in Protein Degradation Pathways Associated with Neurodegenerative Diseases
Current Pharmaceutical Biotechnology Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases
Current Molecular Medicine Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development
Current Molecular Medicine CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer
Current Medicinal Chemistry Alzheimer’s Disease and Environmental Exposure to Lead: The Epidemiologic Evidence and Potential Role of Epigenetics
Current Alzheimer Research Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Current Drug Metabolism High-Throughput Screening Technologies for Botulinum Neurotoxins
Current Topics in Medicinal Chemistry Targeted Lipid Nanoparticles for Antisense Oligonucleotide Delivery
Current Pharmaceutical Biotechnology Lipoxygenase (LOX) Pathway: A Promising Target to Combat Cancer
Current Pharmaceutical Design